Chapter 36 Glanders

  1. Waag DM, DeShazer D: Glanders: new insights into an old disease. In Lindler LE, Lebeda FJ, Korch GW editors: Biological weapons defense: infectious diseases and counterbioterrorism, Totowa, NJ, 2004, Humana Press, pp 209–237.
  2. Wilkinson L: Glanders: medicine and veterinary medicine in common pursuit of a contagious disease. Med Hist 25:363–384, 1981. PUBMED Abstract
  3. Loeffler F: The etiology of Glanders (in German). Arb Kaiserl Gersundh 1:141–198, 1886.
  4. Derbyshire JB: The eradication of glanders in Canada. Can Vet J 43:722–726, 2002. PUBMED Abstract
  5. Quigley M: Veterinary medicine and the American Civil War. Vet Heritage 24:33–37, 2001. PUBMED Abstract
  6. Whitlock GC, Estes DM, Torres AG: Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277:115–122, 2007. PUBMED Abstract
  7. Wheelis M: First shots fired in biological warfare. Nature 395:213, 1998. PUBMED Abstract
  8. Khan AS, Ashford DA: Ready or not: preparedness for bioterrorism. N Engl J Med 345:287–289, 2001. PUBMED Abstract
  9. Schell, MA, Ulrich RL, Ribot WJ, et al: Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Biolol 64(6):1466–1485, 2007. PUBMED Abstract
  10. Galyov EE, Brett PJ, DeShazer D: Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Ann Rev Microbiol 64:495–517, 2010. PUBMED Abstract
  11. Lazar Adler NR, Stevens JM, Stevens MP, et al: Autotransporters and their role in the virulence of Burkholderia pseudomallei and Burkholderia mallei. Front Microbiol 2:151, 2011. PUBMED Abstract
  12. DeShazer D, Waag DM, Fritz DL, et al: Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathogen 30:253–269, 2001. PUBMED Abstract
  13. Lopez J, Copps J, Wilhelmsen C, et al: Characterization of experimental equine glanders. Microbes Infect 5:1125–1131, 2003. PUBMED Abstract
  14. Ulrich RL, DeShazer D, Hines HB, et al: Quorum sensing: a complex transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect Immuno 72:6589–6592, 2004. PUBMED Abstract
  15. Wernery U, Wernery R, Joseph M, et al: Natural Burkholderia mallei infection in a dromedary, Bahrain. Emerg Infect Dis 17(7):1277–1279, 2011. PUBMED Abstract
  16. Al-Ani FK, Robertson J: Glanders in horses: a review of the literature. Veterinarski Arhiv 77(3):203–218, 2007.
  17. Arun S, Neubauer H, Gurel A, et al: Equine glanders in Turkey. Vet Rec 144:255–258, 1999. PUBMED Abstract
  18. Bazargani TT, Tadjbakhs H, Badii A, et al: The outbreak of glanders in some racehorses in three states of Iran. J Equine Vet Sci 16:232–236, 1996.
  19. Krishna L, Gupta VK, Masand MR: Pathomorphological study of possible glanders in soliped in Himachal Pradesh. Indian Vet J 69:211–214, 1992.
  20. Hornstra H, Pearson T, Georgia S, et al: Molecular epidemiology of glanders, Pakistan. Emerg Infect Dis 15(12):2036–2039, 2009. PUBMED Abstract
  21. Muhammad G, Khan MZ, Athar M: Clinico-microbiological and therapeutic aspects of glanders in equines. J Equine Sci 9:93–96, 1998.
  22. Mota RA, Brito MF, Castro FJC, et al: Mormo em equideos nos Estados de Pernambuco e Alagoas. Pes Vet Bras 20:155–159, 2000.
  23. Elschner MC, Klaus CU, Liebler-Tenorio E, et al: Burkholderia mallei infection in a horse imported from Brazil. Eq Vet Ed 21(3):147–150, 2009.
  24. Srinivasan A, Kraus CN, DeShazer D, et al: Glanders in a military research microbiologist. N Engl J Med 345:256–258, 2001. PUBMED Abstract
  25. Bondi SK, Goldberg JB: Strategies toward vaccines against Burkholderia malleiu and Burkholderia pseudomallei. Expert Rev Vaccines 7(9):1357–1365, 2008. PUBMED Abstract
  26. Liguori AP, Warrington SD, Ginther JL, et al: Diversity of 16S-23S rDNA internal transcribed spacer (ITS) reveals phylogenetic relationships in Burkholderia pseudomallei and its near-neighbors. PLoS One 6(12):e23923, 2011. PUBMED Abstract
  27. Gregory BC, Wagg DM: Glanders. In Dembe ZF, editor: Medical aspects of biological warfare, rev ed, Falls Church, VA, 2007, Office of the Surgeon General United States Army and Washington DC, 2007, Borden Institute Walter Reed Army Medical Center, pp 121–146.
  28. OIE Terrestial Manual Chapter 2.5.11 Available at www.oie.int/en/international-standard-setting/terrestial-manual/access-online.
  29. Katz J, Dewald R, Nicholson J: Procedurally similar competitive immunoassay systems for the serodiagnosis of Babesia equi, Babesia caballi, Trypanosoma equiperdum, and Burkholderia mallei infection in horses. J Vet Diagn Invest 12:46–50, 2000. PUBMED Abstract
  30. Sprague LD, Zachariah R, Neubauer H, et al: Prevalence-dependent use of serological tests for diagnosing glanders in horses. BMC Vet Res 5:32, 2009. PUBMED Abstract
  31. Elschner MC, Scholz HC, Melzer F, et al: Use of a Western blot technique for the serodiagnosis of glanders. BMC Vet Res 7:4, 2011. PUBMED Abstract
  32. Neubauer H, Sprague LD, Zacharia R, et al: Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J Vet Med B Infect Dis Vet Public Health 52:201–205, 2005. PUBMED Abstract
  33. Kenny DJ, Russell P, Rogers D, et al: In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 43:2773–2775, 1999. PUBMED Abstract
  34. Heine HS, England MJ, Waag DM, et al: In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother 45:2119–2121, 2001. PUBMED Abstract
  35. Batmanov VP: [Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim]. Antibiot Khimioter 38:18–22, 1993. PUBMED Abstract
  36. Thibault FM, Hernandez E, Vidal DR, et al: Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 54:1134–1138, 2004. PUBMED Abstract
  37. Estes DM, Dow SW, Schweizer HP, et al: Present and future therapeutic strategies for melioidosis and glanders. Expert Rev Anti Infect Ther 8(3):325–328, 2010. PUBMED Abstract
  38. De Groot AS, Ardito M, Moise L, et al: Immunogenic consensus sequence T helper epitopes for a pan-Burkholderia biodefense vaccine. Immunome Res 7:2–7, 2011. PUBMED Abstract
  39. Whitlock GC, Robida MD, Judy BM, et al: Protective antigens against glanders identified by expression library immunization. Front Microbiol 2:227, 2011. PUBMED Abstract
  40. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 49:1–14, 2000.
  41. Robins GD: A study of chronic glanders in man with report of a case: analysis of 156 cases collected from the literature. Stud R Victoria Hosp Montreal 2:1–98, 1906.